Skip to main content

Citius Pharmaceuticals, Inc.

CTXR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001506251

No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.

Superinvestors holding CTXR, Q2 2026

See all superinvestors

No superinvestor reported holding CTXR in Q2 2026.